文献速递冠心病

完全血运重建与仅罪犯病变血运重建治疗ST段抬高型心肌梗死的系统评价与荟萃分析

Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Cardiol · 2020-01-01

该研究系统检索并纳入10项随机临床试验共7030例STEMI合并多支血管病变患者,比较完全血运重建与仅罪犯病变PCI。结果显示完全血运重建与心血管死亡风险降低相关(OR 0.69,95%CI 0.48-0.99),且心血管死亡或新发心梗复合终点亦降低(OR 0.69,95%CI 0.55-0.87),FFR引导与造影引导策略间无显著交互作用。

要点

  • 完全血运重建与心血管死亡风险降低相关(OR 0.69,95%CI 0.48-0.99)。
  • 完全血运重建降低心血管死亡或新发心梗复合终点(OR 0.69,95%CI 0.55-0.87)。

核心结论

  • 在STEMI合并多支血管病变患者中,完全血运重建与仅罪犯病变PCI相比,与心血管死亡率降低相关。
  • FFR引导与造影引导的完全血运重建策略对主要心血管结局无差异关联。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE、Embase、ISI Web of Science和CENTRAL数据库至2019年9月30日。
  • 纳入10项英文随机临床试验,共7030例STEMI合并多支血管病变患者,加权平均随访29.5个月。

关键数值与推荐

  • 完全血运重建与心血管死亡风险降低相关(OR 0.69,95%CI 0.48-0.99)。
  • 完全血运重建与心血管死亡或新发心梗复合终点降低相关(OR 0.69,95%CI 0.55-0.87)。

临床怎么用

  • 对于STEMI合并多支血管病变患者,可考虑行完全血运重建以降低心血管死亡及心血管死亡或新发心梗风险。
  • FFR引导或造影引导的非罪犯病变PCI策略均可用于完全血运重建。

局限性

  • 全因死亡分析中完全血运重建组与仅罪犯病变组的差异无统计学意义(OR 0.84,95%CI 0.67-1.05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Recently, the Complete vs Culprit-Only Revascularization to Treat Multivessel Disease After Early PCI (percutaneous coronary intervention) for STEMI (ST-segment elevation myocardial infarction [MI]) (COMPLETE) trial showed that angiography-guided PCI of the nonculprit lesion with the goal of complete revascularization reduced cardiovascular (CV) death or new MI compared with PCI of the culprit lesion only in STEMI. Whether complete revascularization also reduces CV mortality is uncertain. Moreover, whether the association of complete revascularization with hard clinical outcomes is consistent when fractional flow reserve (FFR)- and angiography-guided strategies are used is unknown. OBJECTIVE: To determine through a systematic review and meta-analysis (1) whether complete revascularization is associated with decreased CV mortality and (2) whether heterogeneity in the association occurs when FFR- and angiography-guided PCI strategies for nonculprit lesions are performed. DATA SOURCES: A systematic search of MEDLINE, Embase, ISI Web of Science, and CENTRAL (Cochrane Central Register of Controlled Trials) from database inception to September 30, 2019, was performed. Conference proceedings were also reviewed from January 1, 2002, to September 30, 2019. STUDY SELECTION: English-language randomized clinical trials comparing complete revascularization vs culprit-lesion-only PCI in patients with STEMI and multivessel disease were included. DATA EXTRACTION AND SYNTHESIS: The combined odds ratio (OR) was calculated with the random-effects model using the Mantel-Haenszel method (sensitivity with fixed-effects model). Heterogeneity was measured using the I2 statistic. Publication bias was evaluated using the inverted funnel plot approach. Data were analyzed from October 2019 to January 2020. MAIN OUTCOMES AND MEASURES: Cardiovascular death and the composite of CV death or new MI. RESULTS: Ten randomized clinical trials involving 7030 unique patients were included. The weighted mean follow-up time was 29.5 months. Complete revascularization was associated with reduced CV death compared with culprit-lesion-only PCI (80 of 3191 [2.5%] vs 106 of 3406 [3.1%]; OR, 0.69 [95% CI, 0.48-0.99]; P = .05; fixed-effects model OR, 0.74 [95% CI, 0.55-0.99]; P = .04). All-cause mortality occurred in 153 of 3426 patients (4.5%) in the complete revascularization group vs 177 of 3604 (4.9%) in the culprit-lesion-only group (OR, 0.84 [95% CI, 0.67-1.05]; P = .13; I2 = 0%). Complete revascularization was associated with a reduced composite of CV death or new MI (192 of 2616 [7.3%] vs 266 of 2586 [10.3%]; OR, 0.69 [95% CI, 0.55-0.87]; P = .001; fixed-effects model OR, 0.69 [95% CI, 0.57-0.84]; P < .001), with no heterogeneity in this outcome when complete revascularization was performed using an FFR-guided strategy (OR, 0.78 [95% CI, 0.43-1.44]) or an angiography-guided strategy (OR, 0.61 [95% CI, 0.38-0.97]; P = .52 for interaction). CONCLUSIONS AND RELEVANCE: In patients with STEMI and multivessel disease, complete revascularization was associated with a reduction in CV mortality compared with culprit-lesion-only PCI. There was no differential association with treatment between FFR- and angiography-guided strategies on major CV outcomes.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Bainey KR, Engstrøm T, Smits PC, et al. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis. JAMA Cardiol. 2020. PMID: 32432651. doi:10.1001/jamacardio.2020.1251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。